The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study

Ted Cohen, Megan Murray, Kristina Wallengren, Gonzalo G Alvarez, Elizabeth Y Samuel, Douglas Wilson, Ted Cohen, Megan Murray, Kristina Wallengren, Gonzalo G Alvarez, Elizabeth Y Samuel, Douglas Wilson

Abstract

Background: Tuberculosis is the leading cause of death in South Africa by death notification, but accurate diagnosis of tuberculosis is challenging in this setting of high HIV prevalence. We conducted limited autopsies on young adults dying in a single public hospital in the province of KwaZulu-Natal between October 2008 and August 2009 in order to estimate the magnitude of deaths attributable to tuberculosis.

Methods and findings: We studied a representative sample of 240 adult inpatients (aged 20-45 years) dying after admission to Edendale Hospital. Limited autopsies included collection of respiratory tract secretions and tissue by needle core biopsies of lung, liver, and spleen. Specimens were examined by fluorescent microscopy for acid-fast bacilli and cultured in liquid media; cultures positive for M. tuberculosis were tested for drug susceptibility to first- and second-line antibiotics. Ninety-four percent of our study cohort was HIV seropositive and 50% of decedents had culture-positive tuberculosis at the time of death. Fifty percent of the participants were on treatment for tuberculosis at the time of death and 58% of these treated individuals remained culture positive at the time of death. Of the 50% not receiving tuberculosis treatment, 42% were culture positive. Seventeen percent of all positive cultures were resistant to both isoniazid and rifampin (i.e., multidrug resistant); 16% of patients dying during the initiation phase of their first ever course of tuberculosis treatment were infected with multidrug-resistant bacilli.

Conclusions: Our findings reveal the immense toll of tuberculosis among HIV-positive individuals in KwaZulu-Natal. The majority of decedents who remained culture positive despite receiving tuberculosis treatment were infected with pan-susceptible M. tuberculosis, suggesting that the diagnosis of tuberculosis was made too late to alter the fatal course of the infection. There is also a significant burden of undetected multidrug-resistant tuberculosis among HIV-coinfected individuals dying in this setting. New public health approaches that improve early diagnosis of tuberculosis and accelerate the initiation of treatment are urgently needed in this setting. Please see later in the article for the Editors' Summary.

Conflict of interest statement

Megan Murray is on the Editorial Board of PLoS Medicine.

References

    1. UNAIDS/WHO Epidemiological Fact Sheet on HIV and AIDS, 2008 Update. Available: .
    1. World Health Organization. Global tuberculosis control – epidemiology, strategy, financing. Geneva: World Health Organization (WHO/HTM/TB/2009.411); 2009.
    1. Colebunders R, Bastian I. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000;4:97–107.
    1. Harries AD, Maher D, Nunn P. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Bull World Health Organ. 1998;76:651–662.
    1. Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SL. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374:921–933.
    1. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575–1580.
    1. Statistics South Africa. Mortality and causes of death in South Africa 2007: finding from death notification. 2009. Available: .
    1. South African Institute of Race Relations. South Africa Survey 2008/2009. Press Report available online ; accessed Dec 12, 2009.
    1. Alvarez GG, Thembela BL, Muller FJ, Clinch J, Singhal N, Cameron DW. Tuberculosis at Edendale Hospital in Pietermaritzburg, Kwazulu Natal, South Africa. Int J Tuberc Lung Dis. 2004;8:1472–1478.
    1. The Italian Cooperation in South Africa, Demographic and Health Indicators KwaZulu-Natal. Public document available online (Accessed 01 March 2010)
    1. National Department of Health, South Africa. The national HIV and syphilis survey, South Africa. 2007. (Accessed 01 March 2010)
    1. Le Couer S, Halembokaka G, Khlat M, Brouard N, Purhuence F, et al. Impact of AIDS on adult mortality: a morgue-based study in Pointe-Noire, Republic of Congo. AIDS. 2005;19:1683–1687.
    1. Webber LM, Swanevelder C, Grabow WO, Fourie P. Evaluation of a rapid test for HIV antibodies in saliva and blood. SA Med. 2000;90:1004–1007.
    1. Zehner R, Bratzke H, Mebs D. Evaluation of a rapid assay system, HIV 1/HIV 2 Testpack, Abbott, to detect human immunodeficiency virus antibodies in postmortem blood. J Forensic Sci. 1995;40:113–115.
    1. Williams PL, Warwick R, Dyson M, Bannister L, editors. Gray's Anatomy, thirty seventh edition. Edinburgh: Churchill Livingstone; 1989.
    1. Guerra I, Ortiz E, Portu J, Atares B, Aldamiz-Etxebarria M, et al. Value of limited necropsy in HIV-positive patients. Pathol Res Pract. 2001;197:165–168.
    1. Satyanarayana S, Kalghatgi AT, Malaviya AK, Bhardwaj JR, Muralidhar A, et al. Needle necropsy in AIDS. Indian J Pathol Microbiol. 2003;46:416–419.
    1. Gutierrez EB, Zanetta DM, Saldiva PH, Capelozzi VL. Autopsy-proven determinants of death in HIV-infected patients treated for pulmonary tuberculosis in Sao Paulo, Brazil. Pathol Res Pract. 2002;198:339–346.
    1. Hanna BA. Laboratory diagnosis. In: Rom WN, Garay SM, editors. Tuberculosis (2nd Edition) Philadelphia: Lippincott Williams and Wilkins; 2004.
    1. Kent PT, Kubica GP. Public Health Mycobacteriology. 1985. A Guide For the Level III Laboratory. Atlanta, U.S department of Health and Human Services, Public Health Service, CDC.
    1. Isenberg HD. Clinical Microbiology Procedures Handbook, vol(1) Chapter 5.13.1. Washington DC: ASM Press; 2004.
    1. Rana FS, Hawken MP, Mwachari C, Bhatt SM, Abdullah F, et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr. 2000;24:23–29.
    1. Echejoh GO, Mandong BM, Tanko MN, Manasseh AN, Okeke EN, et al. Hepatic histopathological findings in HIV patients at postmortem in Jos university teaching hospital, Nigeria. Tropical doctor. 2006;36:228–231.
    1. Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997–1998. Int J Tuberc Lung Dis. 2002;6:55–63.
    1. Martinson NA, Karstaedt A, Venter F, Omar T, King P, et al. Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. AIDS. 2007;21:2043–2050.
    1. Chideya S, Winston CA, Peloquin CA, Bradford WZ, Hopewell PC, et al. Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis. 2009;48:1685–1694.
    1. Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, et al. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. East Afr Med J. 1999;76:307–313.
    1. Meintjes G, Schoeman H, Morroni C, Wilson D, Maartens G. Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional study. BMC Infect Dis. 2008;25:8–72.
    1. Millen SJ, Uys PW, Hargrove J, van Heerden PD, Williams BJ. The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PLoS ONE. 2008;3:e1933.
    1. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Eng J Med. 2010;362:707–16.
    1. Hirao S, Yassin MA, Khamofu HG, Lawson L, Cambanis A, et al. Same-day smears in the diagnosis of tuberculosis. Trop Med Int Health. 2007;12:1459–1463.
    1. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infectious Diseases. 2006;6:664–674.
    1. Marais BJ, Brittle W, Painczyk K, Hesseling AC, Beyers N, et al. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin Infect Dis. 2008;47:203–207.
    1. Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009;30:685–99.
    1. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn. 2006;6:423–432.
    1. Mäkinen j, Marttila HJ, Marjamäki M, Viljanen MK, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2006;44:350–352.
    1. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med. 2008;177:787–792.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe